Role of Sentinel Lymph Node Biopsy in Patients With Thin (<1 mm) Primary Melanoma
Authors:
- 1 June 2003
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 10 (5) , 558-561
Abstract
Background:Thin melanomas have become increasingly prevalent, and lesions ≤1 mm in thickness are frequently diagnosed. They are considered highly curable when treated solely with wide local...Keywords
This publication has 12 references indexed in Scilit:
- No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mmMelanoma Research, 2001
- Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth PhaseAnnals of Surgical Oncology, 2000
- Recent Advances in the Care of the Patient with Malignant MelanomaAnnals of Surgery, 1997
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Surgical Management of Regional Lymph Nodes in Patients with Melanoma Experience with 4682 PatientsAnnals of Surgery, 1994
- Lethal “Thin” Malignant MelanomaAnnals of Surgery, 1988
- Thin Stage I Primary Cutaneous Malignant MelanomaNew England Journal of Medicine, 1988
- Thin Malignant Melanomas and Recurrence PotentialArchives of Surgery, 1987
- A subset in which Level Is the Major Prognostic IndicatorAnnals of Surgery, 1985
- Metastasis and Death in Patients with Thin Melanomas (Less than 0.76 mm)Annals of Surgery, 1983